Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 3Phase 3 3Phase 4 1

Status

Completed 29Terminated 8Active not recruiting 4Unknown 3Recruiting 3

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × bicalutamide × Clear all
NCT00567580 2025-05-09

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Unknown
1,792 enrolled 27 charts
Genitourinary

Prostatic Neoplasms

NCT03520478 2021-03-02

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Unknown
654 enrolled
Genitourinary

Prostatic Neoplasms

NCT00175396 2014-03-17

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

University of British Columbia

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡